NeuroSense Therapeutics Ltd. (NRSN)

NeuroSense Therapeutics Statistics

Total Valuation

NRSN has a market cap or net worth of $29.03 million. The enterprise value is $28.36 million.

Market Cap	29.03M
Enterprise Value	28.36M

Important Dates

The next estimated earnings date is Monday, September 29, 2025, before market open.

Earnings Date	Sep 29, 2025
Ex-Dividend Date	n/a

Share Statistics

NRSN has 24.60 million shares outstanding. The number of shares has increased by 42.40% in one year.

Current Share Class	24.60M
Shares Outstanding	24.60M
Shares Change (YoY)	+42.40%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	49.03%
Owned by Institutions (%)	1.98%
Float	12.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.71

Current Ratio	0.71
Quick Ratio	0.69
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-303.90%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	1,651.25%
Revenue Per Employee	n/a
Profits Per Employee	-$509,294
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.65% in the last 52 weeks. The beta is 1.57, so NRSN's price volatility has been higher than the market average.

Beta (5Y)	1.57
52-Week Price Change	+21.65%
50-Day Moving Average	1.58
200-Day Moving Average	1.31
Relative Strength Index (RSI)	43.76
Average Volume (20 Days)	329,640

Short Selling Information

The latest short interest is 259,802, so 1.06% of the outstanding shares have been sold short.

Short Interest	259,802
Short Previous Month	579,227
Short % of Shares Out	1.06%
Short % of Float	2.07%
Short Ratio (days to cover)	0.68

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.57M
Pretax Income	-10.11M
Net Income	-8.66M
EBITDA	-8.55M
EBIT	-8.57M
Earnings Per Share (EPS)	-$0.38

Balance Sheet

The company has $666,000 in cash and n/a in debt, giving a net cash position of $666,000 or $0.03 per share.

Cash & Cash Equivalents	666,000
Total Debt	n/a
Net Cash	666,000
Net Cash Per Share	$0.03
Equity (Book Value)	-519,000
Book Value Per Share	-0.02
Working Capital	-647,000

Cash Flow

In the last 12 months, operating cash flow was -$8.39 million and capital expenditures -$5,000, giving a free cash flow of -$8.39 million.

Operating Cash Flow	-8.39M
Capital Expenditures	-5,000
Free Cash Flow	-8.39M
FCF Per Share	-$0.34

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NRSN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-42.40%
Shareholder Yield	-42.40%
Earnings Yield	-29.82%
FCF Yield	-28.90%

Analyst Forecast

The average price target for NRSN is $14.00, which is 1,086.44% higher than the current price. The consensus rating is "Buy".

Price Target	$14.00
Price Target Difference	1,086.44%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2